3M V.A.C. Wound Therapy System (KCI) – leak alarm issue (2025)
Hazard assessment based on recall description.
This AI-generated summary is provided for general informational purposes only and is derived from publicly available recall notices. It supplements but does not replace official agency classifications or safety instructions.
Check Your Product
According to the U.S. Food and Drug Administration (FDA)
Product
3M V.A.C. VIA Negative Pressure Wound Therapy System REF: VIAKIT077D01/US - V.A.C. VIA 7 Day Kit VIAKIT07S05/AU - V.A.C. VIA Starter Kit 65-Pack VIAKIT077D01/GB - V.A.C. VIA 7 Day Kit, Single Shipper
Brand
KCI USA, INC.
Lot Codes / Batch Numbers
Not specified in FDA notice. Check official source for details.
Products Sold
VIAKIT077D01/US V.A.C. VIA 7 DAY KIT UDI-DI code: 00849554002388 Assembly Item Number: VIAKIT077D01/USV003 Lot Numbers: C17525V003 C17557V003 VIAKIT07S05/AU V.A.C. VIA STARTER KIT 5-PACK UDI-DI code: 00849554002401 Assembly Item Number: VIAKIT07S05/AUV003 Lot Number: C16937V003 VIAKIT077D01/GB V.A.C. VIA 7 DAY KIT, SINGLE SHIPPER UDI-DI code: 00849554002364 Assembly Item Number: VIAKIT077D01/GBV003 Lot Numbers: C16936V003 C17027V003
KCI USA, INC. is recalling 3M V.A.C. VIA Negative Pressure Wound Therapy System REF: VIAKIT077D01/US - V.A.C. VIA 7 Day Kit VIA due to Due to increase in complaints related to leak alarms. Based on FDA medical device recall database.
Summary derived from FDA notice
Reason for Recall
As stated by FDA
Due to increase in complaints related to leak alarms
Recommended Action
Per FDA guidance
On 01/17/2025, the firm sent an "URGENT - MEDICAL DEVICE RECALL" Letter via US Postal to customers informing them that Solventum has identified that devices distributed between March 11, 2024 and November 18th, 2024 were released with a leak alarm threshold lower than the design specification. This results in the therapy unit prematurely alarming although there is no leak within the system and potentially continuing to alarm during therapy although there is no visible leak. Customers are instructed to: 1.Screen their facility or other storage locations for the impacted products and lot numbers listed in Attachment 1. 2.Immediately cease use and quarantine any identified product. 3.Complete the Field Notice Receipt and Customer Response Form acknowledging that they have received a copy of this notice and select one of two options: a.Acknowledge they do not have any product impacted by the field action. b.Acknowledge they have product impacted by the field action and complete the catalog number, lot numbers and quantities they have identified and quarantined. 4.Return the form via email to kci3mfieldactionresponse@solventum.com. 5.Call Solventum customer service at 1-800-275-4524 to help coordinate the return shipment and receive return labels. 6.Products returned to Solventum will be assessed, reprogrammed, and returned or replaced. a.Product skus and quantities shipped to Solventum will be returned or replaced with the same quantities. b.Returned or replaced product will have a visual identifier confirming the assessment and reprogramming. c.Returned or replaced product may have different lot numbers and expiry dates; Solventum plans to ship available product to help reduce wait times. For any questions, please contact your local Solventum representative, visit Solventum.com or call 800-275-4524.
Verify this information on the official source
For complete details and official instructions, check the U.S. Food and Drug Administration (FDA) directly.
View official FDA recall noticePage updated: Jan 10, 2026